Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 1 institution in 1 country.
Flavia GuarneriIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Cristina BertasioIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.ORCID 0000-0002-1082-982X
Claudia RomeoIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.ORCID 0000-0002-5964-2847
Nicoletta FormentiIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Federico ScaliIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.ORCID 0000-0002-4412-0587
Giovanni ParisioIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Sabrina CanzianiIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Chiara BoifavaIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Federica GuadagnoIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Maria Beatrice BoniottiIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.ORCID 0000-0001-6252-9848
Giovanni Loris AlboraliIstituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna-IZSLER, v. Bianchi 9, 25124 Brescia, Italy.
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini" · IT
Funding
Ministero della Salute PRC2020004
6 · The paper itself
Abstract
The emergence of colistin resistance raises growing concerns because of its use as a last-resort antimicrobial for the treatment of severe gram-negative bacterial infections in humans. Plasmid-borne mobile colistin resistance genes (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.